The Swedish BioFINDER Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)
- Status
- UNKNOWN
- Phase
- N/A
Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of a Diet in Patients With Senile Dementia
- Status
- UNKNOWN
- Phase
- NA
Capacity Assessment in Persons With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Apathy in Alzheimer's Disease With Modafinil
- Status
- COMPLETED
- Phase
- PHASE3
Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients
- Status
- UNKNOWN
- Phase
- PHASE1
An Extension of the CONCERT Protocol (DIM18)
- Status
- TERMINATED
- Phase
- PHASE3
A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
- Status
- COMPLETED
- Phase
- PHASE2
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
- Status
- UNKNOWN
- Phase
- N/A
Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders
- Status
- TERMINATED
- Phase
- NA
Effects of Simvastatin on Biomarkers
- Status
- COMPLETED
- Phase
- PHASE4
Trazodone for Sleep Disorders in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Safety Study of LY2886721 Single Doses in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1